[Federal Register Volume 76, Number 168 (Tuesday, August 30, 2011)]
[Notices]
[Page 53961]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-22089]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated April 15, 2011, and published in the Federal 
Register on April 27, 2011, 76 FR 23627, Cedarburg Pharmaceuticals, 
Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made application by 
letter to the Drug Enforcement Administration (DEA) to be registered as 
a bulk manufacturer of 4-Anilino-N-phenethyl-4-Piperidine (8333), a 
basic class of controlled substance listed in schedule II.
    The company plans to use this controlled substance in the 
manufacturer of another controlled substance.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a), and determined that the registration 
of Cedarburg Pharmaceuticals, Inc., to manufacture the listed basic 
class of controlled substance is consistent with the public interest at 
this time. DEA has investigated Cedarburg Pharmaceuticals, Inc., to 
ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in 
accordance with 21 CFR 1301.33, the above named company is granted 
registration as a bulk manufacturer of the basic class of controlled 
substance listed.

    Dated: August 16, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-22089 Filed 8-29-11; 8:45 am]
BILLING CODE 4410-09-P